The PE Ratio as of November 2024 (TTM) for Amneal Pharmaceuticals, Inc. (AMRX) is -10.65

According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.65. This represents a change of -146.94% compared to the average of 22.69 of the last 4 quarters.

Amneal Pharmaceuticals, Inc. (AMRX) Historical PE Ratio (quarterly & annually)

How has AMRX PE Ratio performed in the past?

The mean historical PE Ratio of Amneal Pharmaceuticals, Inc. over the last ten years is 8.65. The current -10.65 PE Ratio has changed -12408.73% with respect to the historical average. Over the past ten years (40 quarters), AMRX's PE Ratio was at its highest in in the September 2018 quarter at 98.34. The PE Ratio was at its lowest in in the December 2020 quarter at -55.54.

Amneal Pharmaceuticals, Inc. (AMRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amneal Pharmaceuticals, Inc. (AMRX) Average PE Ratio

How has AMRX PE Ratio performed in the past?

The current PE Ratio of Amneal Pharmaceuticals, Inc. (AMRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Amneal Pharmaceuticals, Inc. (AMRX) PE Ratio vs. Peers

How is AMRX’s PE Ratio compared to its peers?

Amneal Pharmaceuticals, Inc.’s PE Ratio is less than Alkermes plc (13.03), less than Neurocrine Biosciences, Inc. (31.58), greater than Intra-Cellular Therapies, Inc. (-105.52), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (89.86), less than Amphastar Pharmaceuticals, Inc. (14.86), less than Collegium Pharmaceutical, Inc. (10.62), less than Ironwood Pharmaceuticals, Inc. (72.33), less than ANI Pharmaceuticals, Inc. (40.06), less than Phibro Animal Health Corporation (372.68), less than Procaps Group S.A. (5.12), less than Silver Spike Investment Corp. (13.39), less than Eagle Pharmaceuticals, Inc. (0.27), greater than Evolus, Inc. (-19.36), less than Agile Therapeutics, Inc. (-0.65), less than Assertio Holdings, Inc. (-0.29), less than AcelRx Pharmaceuticals, Inc. (-1.83), less than Lifecore Biomedical, Inc. (28.27),

Build a custom stock screener for Amneal Pharmaceuticals, Inc. (AMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amneal Pharmaceuticals, Inc. (AMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.